期刊文献+

三种检测方法对变异血红蛋白患者糖化血红蛋白测定结果比较分析 被引量:3

Comparative analysis of glycated hemoglobin A1c values obtained by three test methods in patients with variant hemoglobin
原文传递
导出
摘要 目的 研究3种糖化血红蛋白(HbA1c)检测方法对变异血红蛋白患者HbA1c测定结果的比较分析.方法 收集2012年1月到2012年12月50例不同类型变异血红蛋白患者血样标本为研究对象,血红蛋白D、Q、G、J和E标本共25例,平均年龄(24±3)岁,男14例,女11例;血红蛋白F标本来源于新生儿,共25例,男11例,女14例;同时收集50例无变异血红蛋白标本为对照组,平均年龄(25±5)岁,男25例,女25例.使用亲和层析高效液相色谱(HPLC)法、离子交换HPLC法和免疫法三种方法检测HbA1c.用方差分析和Pearson相关分析法进行数据统计.结果 HbA1c结构正常组使用亲和层析HPLC法Ultra2、离子交换HPLC G8和VariantⅡ、免疫法DCA Vantage四种方法检测HbA1c分别为5.7%±1.1%、5.7%±1.2%、5.7%±1.2%、5.7%±1.1%,各组差异无统计学意义(F=0.023,P>0.05).25例变异血红蛋白F新生儿中,离子交换HPLC法和免疫法均检测不到血红蛋白F中的HbAlc值;空腹血糖与Ultra2检测HbA1c相关(r=0.647,P<0.05);空腹血糖与VariantⅡ和G8及DCA Vantage组的检测结果均无明显相关.亲和层析HPLC法不受血红蛋白D、Q、G、J和E的干扰,与血糖明显相关(r=0.823,P<0.05).离子交换HPLC法检测结果受到血红蛋白D、Q、G、J和E不同程度的干扰;免疫法测定的HbAlc与血糖相关(r=0.611,P<0.05).结论 亲和层析HPLC法测定的HbAlc可更准确地反映平均血糖水平.变异血红蛋白会干扰离子交换HPLC法的HbA1c的检测结果,免疫法检测结果仅受血红蛋白F的干扰. Objective To make comparative analysis of the glycated hemoglobin A1c(HbA1c) values obtained by three HbA1c test methods in patients with variant hemoglobins.Methods Total of 50 blood samples of patients with different types of variant hemoglobin were collected from January 2012 to December 2012; 25 of them (14 males and 11 females) carried hemoglobin D,Q,G,J and E with a mean age of (24±3) years; the other 25 cases (11 males and 14 females) were blood samples with hemoglobin F from newborn infants.Meanwhile,50 blood samples(25 males and 25 females) from people without variant hemoglobins were also collected as control(mean age (25±5) years).Three methods were used to test HbA1c,which were affinity high performance liquid chromatography (HPLC) method (Ultra 2 of American Primus),ion exchange HPLC method (Variant Ⅱ of American Bio-Rad and G8 of Japanese Tosoh) and immunization method (DCA Vantage of German Siemens).The statistic analysis were done with variance analysis and correlation analysis.Results The HbA1c of the group with normal HbA1c structure was 5.7%± 1.1%,5.7%± 1.2%,5.7%±1.2% and 5.7%±1.1% respectively when it was tested by affinity HPLC method (Ultra2),ion exchangc HPLC method (G8),ion exchange HPLC (Variant Ⅱ) and immunization method (DCA Vantage),and there was no significant difference among the groups (F=0.023,P>0.05).In the 25 samples with hemoglobin F,HbAlc could not be detected by ion exchange HPLC or immunoassay method.The fasting blood glucose level correlated with HbA lc level tested by Ultra 2 method (r=0.647,P<0.05),but it didn't correlate with HbA1c level when tested with Variant Ⅱ and G8 as well as DCA Vantage method.The HbA1c result of affinity HPLC method was free from the disturbance of Hb D,Q,G,J and E,and had a obvious correlation with blood glucose (r=0.823,P<0.05).The HbA1c result of ion exchange HPLC method was disturbed by hemoglobin D,Q,G,J and E in varying degrees.The HbA1c measured by immunization method was associated with blood glucose (r=0.611,P<0.05).Conclusion The HbA1c value obtained by affinity HPLC method can accurately reflect the mean blood glucose level.Variant hemoglobins disturb the HbA1c result tested by ion exchange HPLC method,and the immunization test result is only disturbed by hemoglobin F.
出处 《中华糖尿病杂志》 CAS CSCD 2014年第9期665-667,共3页 CHINESE JOURNAL OF DIABETES MELLITUS
关键词 糖化血红蛋白 变异血红蛋白 高效液相色谱 Glycated hemoglobin A1c Variant hemoglobins High performance liquid chromatography
  • 相关文献

参考文献5

  • 1中华医学会糖尿病学分会.中国2型糖尿病防治指南(2010年版)[J].中华糖尿病杂志,2010,2增刊2:1-56.
  • 2Roberts WL,De BK,Brown D,et al.Effects of hemoglobin C and S traits on eight glycohemoglobin methods[J].Clin Chem,2002,48:383-385.
  • 3Weykamp CW,Miedema K,de Haan T,et al.Carbamylated hemoglobin interference in glycohemoglobin assays[J].Clin C hem,1999,45:438-440.
  • 4秦良谊.我国异常血红蛋白发生率、分布及遗传多态性[J].医学研究通讯,2003,32(12):12-14. 被引量:39
  • 5Chu CH,Lam HC,Lee JK,et al.Common hemoglobin variants in southern Taiwan and their effect on the determination of HbA1c by ion-exchange high-performance liquid chromatography[J].J Chin Med Assoc,2009,72:362-367.

二级参考文献4

  • 1Vegel.Motulsky.人类遗传学—问题与方法.罗会元等译.北京:人民卫生出版社,1999.303—305.
  • 2L.M.Cook.群体遗传学.汉槎译.北京:科学出版社,1983.13—18.
  • 3乌鲁木齐部队HB病协作组.新疆各民族117847人血红蛋白病例调查[J].解放军医学杂志,1983,8(5):353-357.
  • 4Hou- jun Li, et al. Abnormal hemoglbin in the Silk Road of China. Hum Genet, 1990, 86:231-235.

共引文献72

同被引文献41

  • 1王海滨,陈康,赵家军,冉兴无,朱大龙,刘超,巴建明,母义明.301悦优血糖仪的性能评估:一项多中心临床试验[J].中华内分泌代谢杂志,2014,30(4). 被引量:5
  • 2潘长玉,中国区合作调查组.中国糖尿病控制现状——指南与实践的差距 亚洲糖尿病治疗现状调查1998,2001及2003年中国区结果介绍[J].国外医学(内分泌学分册),2005,25(3):174-178. 被引量:396
  • 3邹密,蒋利,钟健,倪银星,徐兴森,闫振成,陈静,赵志钢,祝之明.非糖尿病代谢综合征与颈动脉粥样硬化的研究[J].中华老年心脑血管病杂志,2007,9(5):323-325. 被引量:14
  • 4International Expert Committee. International Expert Committee report on the role of the A1C assay in ~he diagnosis of diabetes: response to the International Expert Committee [J ]. Diabetes Care, 2009,32(7) : 1327-1334.
  • 5World Health Organization. Use of glycated haemoglobin(HbAlc)in the diagnosis of diabetes mellitus: abbreviated report of a WHO con- sultation[R]. Geneva, WHO, 2011.
  • 6Clinical and Laboratory Standards Institute. EP15-A2 User verifi- cation of performance for precision and trueness~ approved guide- line[S].2 nd ed. Wayne, PA, USA ~ CLSI, 2005.
  • 7Clinical and Laboratory Standards Institute. EP6-A Evaluation of the linearity of quantitative measurement procedures~ a statistical approach~ approved guideline[S]. Wayne, PA, USA~ NCCLS, 2003.
  • 8Clinical and Laboratory Standards Institute. EPT-A2 Interference testing in clinical chemistry~ approved guideline [S] 2nd ed. Wayne,PA, USA ~ CLSI, 2005.
  • 9Clinical and Laboratory Standards Institute. EP9 A2 Comparison and bias estimation using patient samplesapproved guideline[S]. 2nd ed. Wayne, PA, USA : CLSI, 2010.
  • 10Koga M,KasayarIla S. Clinical impact of glycated albumin as an- other glycemic control marker [J]. Endocr J, 2010,57 (9) : 751- 762.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部